Skip to content
Search

Latest Stories

Crossrail project cost to exceed funding, report says

Crossrail project cost to exceed funding, report says

TOTAL cost of completing the Crossrail project will exceed the given funding, a report by the government spending watchdog revealed.

According to the National Audit Office (NAO) estimates the cost of the new rail link will be between £30 million and £218m above the current funding of £18.8 billion.


The report found "significant issues" that could affect the cost and schedule of the project which was initially due to open in December 2018.

Known as the Elizabeth Line, the route, running from Reading to Essex through central London, has suffered from delays, budget complexities and issues with its construction work and signalling systems over the decade.

Although the central section is expected to open in the first half of 2022, the report said, adding that the full line, from Paddington to Abbey Wood, would not be open until May 2023, four years behind schedule.

Management of the scheme was transferred from Crossrail Ltd to TfL, chaired by mayor of London Sadiq Khan, in October 2020.

NAO head Gareth Davies, said, “Crossrail was further from completion than anyone understood when the Department [for Transport], TfL and Crossrail Ltd reset the programme in 2019.”

"The problems we identified in our previous report have been difficult to address and have continued to affect the programme,” he said.

“...it will require further funding to complete, and there are still significant risks that must be managed as the Elizabeth Line undergoes operational testing,” Davies added.

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less